VanEck Pharmaceutical ETF
50 hedge funds and large institutions have $105M invested in VanEck Pharmaceutical ETF in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.1M | |
| 2 | +$11M | |
| 3 | +$688K | |
| 4 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$323K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$313K |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$2.04M | |
| 3 | -$1.28M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$976K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$952K |